Xiangdong Tian

Tianjin Key Laboratory Of Digestive Cancer, State Key Laboratory Of Druggability Evaluation And Systematic Translational Medicine
Tianjin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

ATP6L impairs vascular stability in colorectal cancer via PDGFB/PDGFRβ signaling.

ATP6L impairs vascular stability in colorectal cancer via PDGFB/PDGFRβ signaling.

Journal: Bioscience trends
Published: August 30, 2026

High PMS2 Expression-Based Nomogram for Risk Stratification in Resected Hepatocellular Carcinoma: Application to Recurrence and Neoadjuvant Therapy Selection.

High PMS2 Expression-Based Nomogram for Risk Stratification in Resected Hepatocellular Carcinoma: Application to Recurrence and Neoadjuvant Therapy Selection.

Journal: Journal of Cancer
Published: January 23, 2026

A lactylation-associated gene signature predicts prognosis in neuroblastoma and identifies RPS6KA6 as a candidate biomarker.

A lactylation-associated gene signature predicts prognosis in neuroblastoma and identifies RPS6KA6 as a candidate biomarker.

Journal: BMC cancer
Published: December 21, 2025

Transcription factor activity-based stratification reveals prognostic subtypes and immune landscape in neuroblastoma.

Transcription factor activity-based stratification reveals prognostic subtypes and immune landscape in neuroblastoma.

Journal: Translational pediatrics
Published: October 27, 2025

LncRNA DANCR promotes ABL2-mediated metastasis via decoying of miR-125a-5p in high-risk neuroblastoma.

LncRNA DANCR promotes ABL2-mediated metastasis via decoying of miR-125a-5p in high-risk neuroblastoma.

Journal: Frontiers in oncology
Published: October 09, 2025

Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma.

Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in Cholangiocarcinoma.

Journal: Liver cancer
Published: August 26, 2025

Survival benefit of adjuvant chemotherapy and individualized prognosis in resected cHCC-CCA.

Survival benefit of adjuvant chemotherapy and individualized prognosis in resected cHCC-CCA.

Journal: Bioscience trends
Published: July 16, 2025

Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancer.

Integrated multi-omics analysis of single-cell and spatial transcriptomics reveals distinct hpv-associated immune microenvironment features and prognostic signatures in cervical cancer.

Journal: Frontiers in immunology
Published: April 25, 2025

Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.

Low SVEP1 in intrahepatic cholangiocarcinoma mediates phenotype switching-driven metastasis by Jag2/Notch1/Hes5.

Journal: Cell death & disease
Published: April 13, 2025

Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy.

Trilaciclib triggers a neutrophil-related immune response and sensitizes non-small cell lung cancer to anti-PD-1 therapy.

Journal: Cell reports. Medicine
Published: February 21, 2025

PLK4 as a Key Regulator of Neuroblastoma Differentiation and a Promising Therapeutic Target.

PLK4 as a Key Regulator of Neuroblastoma Differentiation and a Promising Therapeutic Target.

Journal: International journal of biological sciences
Published: February 03, 2025

Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma.

Inhibition of Wnt/β-catenin increases anti-tumor activity by synergizing with sorafenib in hepatocellular carcinoma.

Journal: Cell death & disease
Published: November 26, 2024
Showing 1-12 of 31

Last Updated: 09/26/2026